Investigating how RNA modifications affect immune responses in blood cell development
The role of m6A RNA modification as modulator of dsRNA induced cell-intrinsic innate immune responses in hematopoiesis
This study is looking at how a special change in RNA affects the immune responses of blood stem cells, which could help us understand conditions like myelodysplasia and leukemia better, ultimately aiming to improve care for patients dealing with these issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10676211 on NIH RePORTER |
What this research studies
This research explores the role of a specific RNA modification, m6A, in regulating immune responses in blood stem cells. By studying how the absence of this modification affects the cells' ability to differentiate and proliferate, the researchers aim to understand the underlying mechanisms that lead to conditions like myelodysplasia and leukemia. The approach involves analyzing the immune signaling pathways activated by double-stranded RNA in these cells, which could reveal new insights into blood cell development and immune function. Patients may benefit from a better understanding of how these processes contribute to their conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with myelodysplasia, refractory anemia with excess blasts, or smoldering leukemia.
Not a fit: Patients with non-hematological conditions or those without any blood disorders may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating blood disorders like myelodysplasia and leukemia.
How similar studies have performed: While the specific focus on m6A RNA modification in hematopoietic stem cells is relatively novel, similar research has shown promise in understanding RNA modifications and their roles in other diseases.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Halene, Stephanie — Yale University
- Study coordinator: Halene, Stephanie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.